文献速递儿童青少年精神焦虑、强迫与应激相关障碍

儿童急性起病神经精神综合征的表观遗传、核糖体与免疫失调

Epigenetic, ribosomal, and immune dysregulation in paediatric acute-onset neuropsychiatric syndrome.
PubMed 文献 · Mol Psychiatry · 2025-08-30

该研究比较了PANS患儿(n=32)、其他神经发育障碍患儿(n=68)与神经典型对照(n=58),发现PANS患儿早期感染报告更多且发育技能丧失。RNA测序显示核糖体生物合成和RNA甲基转移酶通路上调,而线粒体活性、细胞信号、内吞和免疫反应等通路下调。静脉注射免疫球蛋白治疗可逆转这些失调通路。

要点

  • PANS患儿常规免疫检查正常,但RNA测序显示核糖体、表观遗传和免疫通路失调。
  • PANS患儿早期感染报告更多,且更常丧失已获得的发育技能。
  • 静脉注射免疫球蛋白治疗可逆转核糖体、表观遗传和细胞信号通路的失调。

核心结论

  • PANS患儿存在核糖体生物合成和RNA甲基转移酶通路上调,以及线粒体活性、细胞信号、内吞和免疫反应等通路下调。
  • 静脉注射免疫球蛋白治疗可逆转这些失调的核糖体、表观遗传和细胞信号通路。

研究设计与样本

  • 研究纳入PANS患儿(n=32)、其他非PANS神经发育障碍患儿(n=68)和神经典型对照(n=58),总样本n=100。
  • 采用bulk RNA测序(PANS n=20 vs 对照n=15)和单细胞RNA测序(PANS n=2 vs 对照n=2)。
  • 采用外周血单核细胞Toll样受体刺激试验(PANS n=7 vs 对照n=7)。
  • 对PANS患者静脉注射免疫球蛋白治疗前后进行RNA测序(PANS n=9 vs 对照n=10)。

主要发现

  • PANS患儿和其他非PANS神经发育障碍患儿相比神经典型对照,报告有更高的早期儿童感染率和已获得发育技能的丧失。
  • PANS患儿常规免疫测试正常,但bulk RNA测序显示核糖体生物合成和RNA甲基转移酶通路上调。
  • bulk RNA测序还显示线粒体活性、细胞信号、内吞和免疫反应等多种细胞功能通路下调。
  • 单细胞RNA测序确认了上述发现,但显示免疫细胞类型间存在异质性。
  • Toll样受体刺激试验显示PANS患者外周血单核细胞的TNF和白细胞介素-6反应降低(PANS n=7 vs 对照n=7)。

临床怎么用

  • PANS患儿常规免疫检查可能正常,但RNA测序可揭示核糖体、表观遗传和免疫通路失调。
  • 静脉注射免疫球蛋白治疗可逆转PANS中失调的核糖体、表观遗传和细胞信号通路。
  • 鉴于免疫系统在突触修剪和神经发育中的核心作用,这些发现为表观遗传和免疫调节治疗提供了依据。

局限性

  • 单细胞RNA测序样本量小(PANS n=2 vs 对照n=2),需谨慎解释。
  • Toll样受体刺激试验样本量小(PANS n=7 vs 对照n=7)。
  • 静脉注射免疫球蛋白治疗前后RNA测序样本量小(PANS n=9 vs 对照n=10)。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Paediatric Acute-Onset Neuropsychiatric Syndrome (PANS) is characterised by abrupt onset obsessive compulsive disorder and regression in neurodevelopmental skills, triggered by infection or stress. Whether PANS is a distinct entity or part of a neurodevelopmental spectrum is uncertain, and its pathophysiology remains unclear. We show that children with PANS (n = 32) and other non-PANS (n = 68) neurodevelopmental disorders (total n = 100) have higher reported early childhood infections and a loss of previously acquired developmental skills compared to neurotypical controls (n = 58). Children with PANS have normal routine immune testing, however bulk RNA-sequencing (PANS n = 20 vs controls n = 15) revealed upregulated pathways in ribosomal biogenesis and RNA methyltransferases, and downregulated pathways in diverse cellular functions such as mitochondrial activity, cell signalling, endocytosis, and immune responses. Single-cell RNA-sequencing (PANS n = 2 vs controls n = 2) confirmed these findings but showed heterogeneity across immune cell types. Toll-like receptor stimulation assay using peripheral blood mononuclear cells revealed reduced TNF and interleukin-6 responses in PANS patients (n = 7) compared to controls (n = 7). RNA sequencing before and after intravenous immunoglobulin treatment in PANS patients (n = 9 vs controls n = 10) revealed reversal of the dysregulated ribosomal, epigenetic, and cell signaling pathways. Given the central role of the immune system in synaptic pruning and neurodevelopment, these insights provide rationale for novel epigenetic and immune modulating therapies to optimize neurodevelopmental trajectories and minimize neuropsychiatric impairment in PANS.

来源:Mol Psychiatry,查看原文。版权归原作者所有。

引用

  1. Han VX, Alshammery S, Keating BA, et al. Epigenetic, ribosomal, and immune dysregulation in paediatric acute-onset neuropsychiatric syndrome. Mol Psychiatry. 2025. PMID: 40885847. doi:10.1038/s41380-025-03127-5

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。